Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F J Bemelman

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Transplant Immunology|January 1, 1994
Sequestration of labelled granulocytes in the lungs following administration of OKT3 is dose-dependentF J Bemelman, K J Parlevliet, P T Schellekens, et al.
Clinical and Experimental Immunology|December 8, 2007
The pyrimidin analogue cyclopentenyl cytosine induces alloantigen-specific non-responsiveness of human T lymphocytesN Nikolaeva, F J Bemelman, S-L Yong, et al.
Clinical and Experimental Immunology|August 22, 2003
Treatment of acute kidney allograft rejection with a non-mitogenic CD3 antibodyR T Meijer, S Surachno, S L Yong, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 6, 2016
Incidence, risk factors, and the impact of allograft pyelonephritis on renal allograft functionR Singh, S E Geerlings, H Peters-Sengers, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 1, 2009
Mumps: not an innocent bystander in solid organ transplantationM C Baas, K A M I van Donselaar, S Florquin, et al.
Urologia Internationalis|January 31, 2012
Ureteral reconstruction after renal transplantation: clinical outcome and risk factorsV P Alberts, R C Minnee, F J Bemelman, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1995
Toxicity of OKT3 increases with dosage: a controlled study in renal transplant recipientsK J Parlevliet, F J Bemelman, S L Yong, et al.
Kidney International|May 1, 1993
Complement activation during OKT3 treatment: a possible explanation for respiratory side effectsM H Raasveld, F J Bemelman, P T Schellekens, et al.
The Netherlands Journal of Medicine|June 17, 2014
Treatment efficacy of hypertension in kidney transplant recipients in the NetherlandsL C Dobrowolski, F J Bemelman, K A M I van Donselaar-van der Pant, et al.
Transplantation Proceedings|November 5, 2013
Duplicated ureters and renal transplantation: a case-control study and review of the literatureV P Alberts, R C Minnee, K A M I van Donselaar-van der Pant, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Transplant Immunology|January 1, 1994
Sequestration of labelled granulocytes in the lungs following administration of OKT3 is dose-dependentF J Bemelman, K J Parlevliet, P T Schellekens, et al.
Clinical and Experimental Immunology|December 8, 2007
The pyrimidin analogue cyclopentenyl cytosine induces alloantigen-specific non-responsiveness of human T lymphocytesN Nikolaeva, F J Bemelman, S-L Yong, et al.
Clinical and Experimental Immunology|August 22, 2003
Treatment of acute kidney allograft rejection with a non-mitogenic CD3 antibodyR T Meijer, S Surachno, S L Yong, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 6, 2016
Incidence, risk factors, and the impact of allograft pyelonephritis on renal allograft functionR Singh, S E Geerlings, H Peters-Sengers, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 1, 2009
Mumps: not an innocent bystander in solid organ transplantationM C Baas, K A M I van Donselaar, S Florquin, et al.
Urologia Internationalis|January 31, 2012
Ureteral reconstruction after renal transplantation: clinical outcome and risk factorsV P Alberts, R C Minnee, F J Bemelman, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1995
Toxicity of OKT3 increases with dosage: a controlled study in renal transplant recipientsK J Parlevliet, F J Bemelman, S L Yong, et al.
Kidney International|May 1, 1993
Complement activation during OKT3 treatment: a possible explanation for respiratory side effectsM H Raasveld, F J Bemelman, P T Schellekens, et al.
The Netherlands Journal of Medicine|June 17, 2014
Treatment efficacy of hypertension in kidney transplant recipients in the NetherlandsL C Dobrowolski, F J Bemelman, K A M I van Donselaar-van der Pant, et al.
Transplantation Proceedings|November 5, 2013
Duplicated ureters and renal transplantation: a case-control study and review of the literatureV P Alberts, R C Minnee, K A M I van Donselaar-van der Pant, et al.
Pageof 6